Safety and efficacy of Dolutegravir and EFV400 for pregnant and breastfeeding women: a randomized non-inferiority clinical trial. Expected outcomes include generating scientific evidence to support the use of EFV400 and DTG for pregnant and breastfeeding women, generating evidence on the safety of EFV400 and DTG for pregnant and breastfeeding women. PK/PD/PGx data will also be generated to further support the dosing of EFV and DTG during pregnancy and breastfeeding. Read project presentation and work packages.
